AUG 21, 2018 11:49 PM PDT

'Zombie' gene returns to life and kills cancer in elephants

Researchers have discovered a gene that can protect elephants from cancer.

An estimated 17 percent of humans worldwide die from cancer, but less than five percent of captive elephants—who live for about 70 years, and have about 100 times as many potentially cancerous cells as humans—die from the disease.

Unexpectedly, however, the researchers found that elephants have 20 copies of p53. This makes their cells significantly more sensitive to damaged DNA and quicker to engage in cellular suicide.Three years ago, researchers began to unravel why. They knew that humans, like all other animals, have one copy of the master tumor suppressor gene p53. This gene enables humans and elephants to recognize unrepaired DNA damage, a precursor of cancer. Then it causes those damaged cells to die.

In a paper in the journal Cell Reports, the team also describes a second element of this process: an anti-cancer gene that returned from the dead.

“Genes duplicate all the time,” says senior study author Vincent Lynch, assistant professor of human genetics at the University of Chicago. “Sometimes they make mistakes, producing non-functional versions known as pseudogenes. We often refer to these dismissively as dead genes.”

While studying p53 in elephants, however, Lynch and colleagues found a former pseudogene called leukemia inhibitory factor 6 (LIF6) that had somehow evolved a new on-switch. LIF6, back from the dead, had become a valuable working gene.

Its function, when activated by p53, is to respond to damaged DNA by killing the cell. The LIF6 gene makes a protein that goes, quite rapidly, to the mitochondria, the cell’s main energy source. That protein pokes holes in the mitochondria, causing the cell to die.

“Hence, zombie,” says Lynch. “This dead gene came back to life. When it gets turned on by damaged DNA, it kills that cell, quickly. This is beneficial, because it acts in response to genetic mistakes, errors made when the DNA is being repaired. Getting rid of that cell can prevent a subsequent cancer.”

Elephants have eight LIF genes, but only LIF6 is known to be functional. Although researchers only recently described it, the gene appears to have been helping elephants and their relatives for a long time.

“We can use the tricks of evolution to try to figure out when this defunct gene became functional again,” Lynch says. It seems to have emerged around the time when the fossil record indicates that the small groundhog-sized precursors of today’s elephants began to grow bigger. This started about 25 to 30 million years ago. This supplementary method of suppressing cancer may have been a key element enabling enormous growth, which eventually led to modern elephants.

There are significant and lasting benefits to being huge. Small animals, for example—mice, squirrels, groundhogs—get eaten all the time, mostly by larger animals. But “if you are enormous, such as an elephant or a whale, nothing is going to mess with you,” Lynch says

There are tradeoffs, however. Bigger animals have vastly more cells, and they tend to live longer, which means more time and opportunities to accumulate cancer-causing mutations. When those cells divide, their DNA makes copies of itself. But those copies don’t match the original. Errors get introduced and the repair process can’t catch up.

“Large, long-lived animals must have evolved robust mechanisms to either suppress or eliminate cancerous cells in order to live as long as they do, and reach their adult sizes,” says study coauthor Juan Manuel Vazquez, a doctoral candidate in the Lynch laboratory.

These huge animals thus have higher odds of developing cancerous cells. This can also happen on a smaller scale. Taller humans, for example, have a slightly higher incidence of several cancer types than average sized people, and shorter people tend to be at a reduced risk for those cancers.

LIF6, the study authors suggest, was “reanimated sometime before the demands of maintaining a larger body existed.” It helped enable the growth of animals that were the size of a 10-pound groundhog into majestic creatures that can weigh more than 15,000 pounds. It was “permissive for the origin of large bodies,” the authors note, “but not sufficient.”

Exactly how LIF6 induces apoptosis, however, remains unclear. This will be “the focus of continued studies,” the authors write.

The University of Chicago funded this study through a new lab startup account to Lynch.

Source: University of Chicago

 

This article was originally published on Futurity.org.

About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
NOV 17, 2019
Cancer
NOV 17, 2019
Understanding TP53's role in cancer
New research published in the journal Cell Reports sheds light on the role of the TP53 gene in preventing the spread of cancer. The TP53 gene codes tumor p...
NOV 17, 2019
Cancer
NOV 17, 2019
The anti-cancer flower
Perhaps you have heard of feverfew, a quite common flowering plant that graces many home gardens. Its cute white petals may bring a smile to your lips &nda...
NOV 17, 2019
Cancer
NOV 17, 2019
Not the fried food!
Stop! Put down those fries! Although we know that fried foods aren’t good for our health (though they sure do taste good!), new research from UMass A...
NOV 17, 2019
Cancer
NOV 17, 2019
Cancer drugs don't work the way we thought
New research recently published in the journal Science Translational Medicine surprises the oncological community with findings that a protein previously t...
NOV 17, 2019
Cancer
NOV 17, 2019
Blood test to predict prostate cancer
A study published recently in the Journal of Urology details the results from a new type of blood test that is capable of diagnosing prostate cancer. The i...
NOV 17, 2019
Cancer
NOV 17, 2019
Electronic "nose" sniffs out the best cancer treatment
Can you imagine an electronic device that is capable of figuring out which lung cancer patients will respond best to immunotherapy? If so, now try to imagi...
Loading Comments...